TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EBS

Emergent Biosolutions Inc

Healthcare · Drug Manufacturers - Specialty & Generic

6.80$ -3.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Emergent Biosolutions Inc (EBS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,319 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EBS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
945 1,044 970 1,070 2,229 2,327 2,883 2,958 3,166 1,823 1,390 1,319
432 539 510 485 621 686 1,196 1,270 1,210 680 599 663
280 313 272 178 112 168 621 576 643 112 100 205
280 313 272 178 112 168 621 576 643 112 100 205
60 127 148 146 263 275 231 279 159 191 155 84
66 77 74 143 206 223 307 345 351 329 312 343
314 332 376 407 510 542 644 800 818 399 282 216
42 55 41 49 260 267 267 225 218 218 – –
136 100 34 120 812 742 663 605 729 567 502 437
392 384 374 158 1,219 1,239 1,436 1,346 1,779 1,174 907 796
93 100 106 100 200 216 385 374 1,229 651 162 132
40 43 20 43 10 16 45 37 963 414 2.7 0.0
41 46 35 42 81 95 136 129 104 112 61 56
251 253 248 13 785 798 841 809 449 447 664 572
553 660 596 912 1,011 1,089 1,447 1,612 1,388 649 483 523
288 351 254 337 367 422 727 950 739 -22 -212 -160
46 47 49 50 51 52 54 54 50 51 53 57

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?